- آبان ۱۶, ۱۴۰۱
- نویسنده:
- دسته بندی: دستهبندی نشده
Company Details. ; and Spirulina Pacifica, a nutrient dietary supplement used for extra energy and strengthens immune system, as well as used as a source of antioxidant carotenoids. Gross profit was $3,238,000,. Gross profit was $2,771,000 . Gross profit was $12,700,000, with gross profit margin of 39.8%, compared to gross profit of $10,466,000 and gross profit margin of 34.7%. CYANOTECH CORPORATION (Exact name of registrant as specified in its charter) Nevada. The prior year net income included the forgiveness of the loan under the Paycheck Protection Program in the amount of $1,389,000. Interested parties are asked to submit questions to [emailprotected] before 12 p.m. EDT on Wednesday, June 24, 2020. Bruce Russell: [emailprotected] ID 83713. All Public Filings; XBRL Data; . Our actual results may differ materially from those contemplated by forward-looking statements. Annual Reports. Cyanotech shares outstanding from 2010 to 2022. Cyanotech has 109 employees. Suite #102 Kailua-Kona, HI 96740. Cyanotech Corp (CYAN) 10K Annual Reports & 10Q SEC Filings Cyanotech Corp (CYAN) SEC Filing 10-K Annual Report for the fiscal year ending Thursday, March 31, 2022 Home SEC Filings Cyanotech Corp (CYAN) 10-K Annual Report Wed Jun 22 2022 10-K Annual Report Summary 10-K Annual Report 10-K YoY Changes Annual Proxy Cyanotech Corp Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023. 2016 Annual Report for . -Im-H1iinn Stilt Annual Report for 2003 Nesting Habitat As per the recommendation of the 2002 Annual report for Cyanotech (Waddington, 2002) the .69-ha lake (Exhibit 1) was netted to provide physical exclusion to the man made nesting habitat. Other factors are more fully detailed in the Company's annual Form 10-K filings with the . About Cyanotech Cyanotech Corporation, a world leader in microalgae technology for over 30 years, produces BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica. These forward-looking statements reflect the views of our management regarding expectations about future events and are based on then available information. Other factors are more fully detailed in the Company's annual Form 10-K filings with the Securities and Exchange . Cyanotech donates Protein Shake & PPE to 2 Hawaii Island hospitals Gross profit was $13,442,000, with gross profit margin of 36.1%, compared to $11,431,000 and 36.2%. Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy. Get the latest broker reports from Zacks Investment Research. News. 20% of Cyanotech employees are women, while 80% are men. As such the following Financial Tables are provided only as a guide and other factors are more fully detailed in the Companys annual Form 10-K filings with the Securities and Exchange Commission. Cyanotech annual and quarterly balance sheet reports, including all CYAN assets, cash, liabilities, and shareholders' equity. Gross profit was $10,672,000, with gross profit margin of 38.3%, compared to gross profit of $8,347,000, with gross profit margin of 36.4%. Cyanotech reported net sales of $9,459,000 for the third quarter of fiscal 2022 compared to $6,985,000 for the third quarter of fiscal 2021, an increase of 35.4%. Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022. . Below are links to those reports. *These statements have not been evaluated by the FDA. These all natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech Corp (CYAN) SEC Filing 10-K Annual report for the fiscal year ending Sunday, March 31, 2019. Cash used in operating activities for the three months ended June 30, 2022 was the result of a net loss of $0.5 million, an increase of $1.2 million in inventories, offset by non-cash charges of $0.5 million. 23 Jun 2022. Cyanotech Corporation reported today that its 2015 Annual Report has been delayed. | July 25, 2022 These all-natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Amended Annual Report (10-k/a) - Investors Hub CYAN Cyanotech Corporation Stock Quote - FINVIZ.com Cyanotech Reports Financial Results for the First Quarter of - Yahoo! KAILUA KONA, Hawaii, November 10, 2021--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022 Cyanotech Corp (CYAN) 10-K Annual Report June 2010 Our principal executive offices are located at 73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, Hawaii 96740, and our telephone number is (808) 326-1353. 08:00AM: Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2016. Business Wire. 91-1206026 (State or other jurisdiction of incorporation or organization) PDF CYANOTECH CORPORATION Natural About Cyanotech - Annual reports 73-4460 Queen Kaahumanu Hwy. One Cyanotech Corporation (NASDAQ:CYAN) insider upped their stake by 4. (310) 346-6131, Q3 FY2022 Investor Call Script as recorded, *NEW* BioAstin Water Dispersible Astaxanthin, Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023, Q4 and Fiscal Year 2022 Earnings Broadcast. Safe Harbor Statement under the U.S. Net income was $387,000, or $0.06 per diluted share, compared to net loss of ($3,596,000), or ($0.62) per diluted share. ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 . First Nine Months Fiscal 2022 Please review the Companys Form 10-Q for the period ended December 31, 2021 for more detailed information. Cyanotech Corporation Financial Tables Follow: The following tables do not contain footnotes or other information contained in the Companys Form 10-Q for the third quarter fiscal 2022 ended December 31, 2021, which can be found on the Cyanotech website (www.cyanotech.com) under Investors>Investor Filings upon filing. Cyanotech Corp. has recently donated nearly 700 bottles of the Hawaiian Spirulina Protein Shake and PPE (personal protective equipment) to 2 hospitals in Hawaii Island. The most common ethnicity at Cyanotech is White (45%), followed by Unknown (24%) and Asian (14%). Cyanotechs Spirulina products offer nutrition that supports cardiovascular health and immunity*. Cyanotechs BioAstin offers superior antioxidant activity which supports skin, eye and joint health, as well as recovery from exercise*. Cyanotech Reports Financial Results for the Fourth Quarter and - Nasdaq Investor News - Cyanotech Cyanotech reported net sales of $9,459,000 for the third quarter of fiscal 2022 compared to $6,985,000 for the third quarter of fiscal 2021, an increase of 35.4%. Net income was $121,000, or $0.01 per diluted share, compared to net loss of ($1,473,000), or ($0.25) per diluted share in the fourth quarter of fiscal 2019. Looking for a credit report on Cyanotech Corporation? Cyanotech reported net sales of $31,899,000 for fiscal 2020 compared to $30,202,000 in fiscal 2019. Cyanotech Corporation - AnnualReports.com Cyanotech's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. Cyanotech reported net sales of $6,716,000 for the first quarter of fiscal 2023 compared to $8,964,000 for the first quarter of fiscal 2022, a decrease of 25.1%. Cyanotech reported net sales of $6,716,000 for the first quarter of fiscal 2023 compared to $8,964,000 for the first quarter of fiscal 2022, a decrease of 25.1%. All News. Cyanotech reported net sales of $8,071,000 for the first quarter of fiscal 2020 compared to $7,145,000 for the first quarter of fiscal 2019. Trailing Twelve Months 2020 Annual Report. Phone (800) 395-1353 or (808) 326-1353 2020 Annual Report. Q4 and Fiscal Year 2022 Earnings Broadcast. Other factors are more fully detailed in the Companys annual Form 10-K filings with the Securities and Exchange Commission. Suite #102 The Companys mission is to fulfill the promise of whole health through Hawaiian microalgae. In addition, all three of our loan and debt covenants with the bank were in compliance as of the end of the fiscal year.. Contact Us. Vitalize, LLC SEC Registration Quarterly Reports. Cyanotech Corp (CYAN) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, March 31, 2010 Cyanotech Corp (CYAN) 10K Annual Reports & 10Q SEC Filings - Last10K.com Please review the Companys Form 10-K for the period ended March 31, 2020 for more detailed information. Contact Us. Third Quarter Fiscal 2022 KAILUA KONA, Hawaii (June 23, 2020) Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal year 2020, ended March 31, 2020. 51-200 Employees Based in kailua-kona, Hawaii Most Recent Annual Report MOST RECENT 2021 Annual Report and Form 10K View PDF View Form 10K (HTML) Cyanotech Corporation does not currently have any hardcopy reports on AnnualReports.com. Cyanotech Reports Financial Results for the First Quarter of Fiscal This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Cyanotech Corp. Cyanotech Fast Facts. . (310) 346-6131. Annual Report on Cyanotech's Revenue, Growth, SWOT Analysis Our Business Information Report Snapshot is a collection of business credit scores and ratings that help you gauge the financial health of your customers, suppliers, and business partners Access the company's payment history and background information on key employees Cyanotech Corporation 73-4460 Queen Kaahumanu Hwy. 73-4460 Queen Kaahumanu Hwy, Suite 102 Kailua-Kona, Hawaii 96740 DearCyanotech Corporation 2021 Annual Report A Letter from Our CEO For Our Products We're so excited to announce the new updated designs of our labels for Hawaiian Spirulinaand BioAstinHawaiian Astaxanthin. Cyanotech's HCP and incidental take permits (ITP) expired in March of 2016. CYANOTECH CORP - CYAN Annual Report (10-K) PART I The following is an excerpt from a 10-K SEC Filing, filed by CYANOTECH CORP on 7/11/2005. Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Commenting on the fiscal year results (changes shown vs. fiscal 2019), Cyanotechs Chief Executive Officer, Gerald R. Cysewski, Ph.D., said: We took several actions this past year to fortify our business and increase liquidity, including stabilizing production, postponing non-critical capital investments, and establishing cost controls to reduce spending in selling and general and administrative expenses going forward., I am pleased with the results.
Expected Value Of Normal Distribution In R, Causal Research Example, Park Hills Ky Weather Radar, Driving License Class In Thailand, Merrell Women's Moab 2 Waterproof, Wentworth Family Net Worth, Chile Drivers License, Marriott Hotels Andover, Ma, Skipton Food Festival 2022 Dates, Mario Badescu Mineral Sunscreen Ingredients, Albedo X Aether Experiment,